Drug
Smofkabiven Emulsion For Infusion
Smofkabiven Emulsion For Infusion: highest development phase Phase 3, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| SmofKabiven emulsion for infusion NCT03792100 | Phase 3 | Parenteral Nutrition |
Latest
No recent events.
Follow Smofkabiven Emulsion For Infusion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.